Chagasa heart disease in Europe: An emergent disease?

Journal of Cardiovascular Medicine

Volumn 9, Issue 12, 2008, Pages 1263-1267

  Dobarro, David ^a   Gomez Rubin, Carmen ^a   Sanchez Recalde, Angel ^a   Olias, Fernando ^a   Bret Zurita, Montserrat ^b   Cuesta Lopez, Emilio ^b   Robles Marhuenda, Angel ^b   Fraile Vicente, Jose Maria ^b   Paño Pardo, Jose Ramon ^b   Lopez Sendon, Jose ^a  

^a ALa Paza Universitary Hospital   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ENALAPRIL; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; ASTHENIA; BLOOD SAMPLING; BRADYCARDIA; CASE REPORT; CHAGAS DISEASE; CHRONIC DISEASE; DYSKINESIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MURMUR; HEART MUSCLE FIBROSIS; HEART PALPITATION; HEART RIGHT BUNDLE BRANCH BLOCK; HOLTER MONITORING; HUMAN; HYPOKINESIA; HYPOTENSION; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; SEROLOGY; SINUS BRADYCARDIA; SYNCOPE; THORAX PAIN; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRYPANOSOMA CRUZI; COMMUNICABLE DISEASE; MIDDLE AGED; MIGRATION;

ADULT; CHAGAS CARDIOMYOPATHY; COMMUNICABLE DISEASES, EMERGING; EMIGRANTS AND IMMIGRANTS; EUROPE; FEMALE; HUMANS; MIDDLE AGED;

EID: 59449096096     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32830eb6fe     Document Type: Article

References (22)

1. Punukollu G, Gowda RM, Khan IA, Navarro VS, Vasavada BC. Clinical aspects of the Chagas' heart disease. Int J Cardiol 2007; 115:279-283.
2. Rosas F, Guhl F, Velasco VM, Nicholls RS, Villegas F, Betancourt JF, et al. Chagas' cardiomyopathy. In: Rosas F, Vanegas D, Cabrales M, editors. Chagas' disease. 1st ed. Colombian society of cardiology and cardiovascular surgery; 2007. pp. 47-62.
3. World Health Organization. WHO Expert Committee on the Control of Chagas Disease. Control of Chagas disease: second report of the WHO Expert Committee. Geneva: WHO; 2002. OMS, Technical Reports Series No. 905. http://whqlibdoc.who. int/trs/WHO-TRS-905-spa.pdf.
4. Luquetti AO, Tavares SBN, Oliveira RA, Oliveira EC, Vaz MGM, Rassi A. Presence of specific IgM class antibodies in the different clinical presentations of the chronic Chagas'disease.. Rev Soc Bras Med Trop 1996; 29 (Suppl I):134-135.
5. Acquatella H. Echocardiography in Chagas heart disease. Circulation 2007; 115:1124-1131.
6. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol 2005; 46:1553-1558.
7. Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298:2171-2181.
8. Pedrosa MC, Campos MC. Exercise testing and 24h Holter monitoring in the detection of complex ventricular arrhythmias in different stages of chronic Chagas' heart disease. Rev Soc Bras Med Trop 2004; 37:376-383.
9. Gascón J, Albajar P, Cañas E, Flores M, Gomez i Prat J, Herrera R, et al. Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic. Rev Esp Cardiol 2007; 60:285-293.
10. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation 2007; 115:1101-1108.
11. Ministry of Health. Health vigilance secretary. Brazilian Consensus on Chagas disease. Rev Soc Bras Med Trop 2005; 38:7-29.
12. Botoni FA, Poole-Wilson PA, Ribeiro ALP, Okonko DA, Oliveira BMR, Pinto AS, et al. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas' cardiomyopathy. Am Heart J 2007; 153:5441e-5448e.
13. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Álvarez MG, et al. Long-term cardiac outcomes of threating chronic Chagas disease with benznidazole versus no treatment. Ann Intern Med 2006; 144:724-734.
14. The BENEFIT trial: evaluation of the use of an antiparasital drug (benznidazole) in the treatment of chronic Chagas' disease. http:// clinicaltrials.gov/ct2/show/NCT00123916. [Accessed 20 May 2008].
15. Pihl T, Strand EA, Strand øA, Ohm OJ. Chagas disease in Norway. Tidsskr Nor Laegeforen 2007; 127:1820-1823.
16. Marcu CB, Beek AM, Van Rossum AC. Chagas' heart disease diagnosed on MRI: the importance of patient 'geographic' history. Int J Cardiol 2007; 117:e58-e60.
17. Florian Sanz F, Gomez Navarro C, Castrillo García N, Pedrote Martínez A, Lage Gallé E. Chagasic cardiomyopathy in Spain: a diagnosis to bear in mind. An Med Interna 2005; 22:538-540.
18. Sztajcel J, Cox J, Pache JC, Badaoui E, Lerch R, Rutishauser W. Chagas' disease may also be encountered in Europe. Eur Heart J 1996; 17:1289.
19. Brisseau JM, Cebron JP, Petit T, Marjolet M, Cuillere P, Godin J, Grolleau JY. Chagas' myocarditis imported into France. Lancet 1988; 1:1046.
20. Schmunis A. Pan American Health Organization. World Health Organization. Epidemiology of Chagas disease in non endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007; 102:75-85.
21. Spanish Blood Transfusion Society. Guidelines for the blood transfusions and its components and plasma-derivatives. 3rd ed. Spanish Blood Transfusion Society; 2006.
22. Spanish Society of Infectious Diseases and Clinical Microbiology. Procedures in clinical microbiology. Microbiology of the transplant; 1993.